(CIDRAP News) – Another patient in China has died from an H7N9 influenza infection, raising the number of fatal illnesses to 32, though no new cases were reported today, holding the overall case total to 131.
The World Health Organization (WHO) reported the death today in an update based on information from China's National Health and Family Planning Commission.
(CIDRAP News) – Three provinces in eastern China that have already reported several H7N9 avian flu infections each announced a new case today, bringing the country's total to 64 cases, according to official and media sources.
(CIDRAP News) – Experts are puzzled by a new study in which influenza vaccination seemed to provide little or no protection against flu in the 2010-11 season—and in which the only participants who seemed to benefit from the vaccine were those who hadn't been vaccinated the season before.
(CIDRAP News) – The nation's flu markers show that the flu has probably peaked, though many states are still reporting plenty of infections and hospitalizations, the US Centers for Disease Control and Prevention (CDC) said today.
Though the percentage of doctors' visits for influenza-like illness (ILI) is still above baselines in all regions of the country, the overall national level fell from 3.6% to 3.2% last week, according to the CDC.
(CIDRAP News) Flu activity is increasing in many of the Northern Hemisphere's temperate-zone countries, with influenza B cocirculating with the 2009 pandemic H1N1 virus across Europe and teaming up with influenza A (H3N2) in the United States and Canada, the World Health Organization (WHO) said in its latest update.
(CIDRAP News) European officials yesterday reported more evidence that one of the three types of seasonal influenza viruses is showing resistance to oseltamivir (Tamiflu) and said this represents the first clear sign that the resistant variant can spread.
(CIDRAP News) This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.